Novavax, que tiene su sede en Gaithersburg e instalaciones en Rockville, anunció que ha pasado a la Fase 3 de su ensayo de eficacia para su vacuna COVID-19. Prevent-19 está diseñado para determinar la eficacia, seguridad e inmunogenicidad de su vacuna. Se espera inscribir hasta 30.000 voluntarios en todo Estados Unidos y México, de los […]
Dr. Francis S. Collins
January 4, 2021 |
December 31, 2020 |
Close to ‘Finish Line,’ Novavax Enters Phase 3 Trials for COVID-19 Vaccine
Novavax, which is headquartered in Gaithersburg and has facilities in Rockville, announced it has moved into Phase 3 of its efficacy trial for its COVID-19 vaccine. Prevent-19 is designed to determine the efficacy, safety and immunogenicity of its vaccine. It expects to enroll up to 30,000 volunteers throughout the United States and Mexico, of which […]
March 31, 2015 |
Mikulski to Tour NIH in Rockville Today
U.S. Senator Barbara A. Mikulski (D-Md.), Vice Chairwoman of the Senate Appropriations Committee, is scheduled to tour the National Institutes of Health’s (NIH) National Center for Advancing Translational Sciences (NCATS) in Rockville this morning, and call for increased support and investment in the physical and human infrastructure of NIH. Mikulski will announce that she is […]
Engage us on Facebook
Follow us on Twitter
Tweets by @mymcmedia